Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer.
Antibodies (Basel)
; 8(4)2019 Nov 05.
Article
in En
| MEDLINE
| ID: mdl-31694242
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Antibodies (Basel)
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: